NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers

Go back to NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
(NASDAQ: NXTC) Delayed: 1.89 +0.14 (8.00%)
Previous Close $1.75    52 Week High
Open $1.70    52 Week Low
Day High $1.89    P/E N/A 
Day Low $1.65    EPS
Volume 67,939